Literature DB >> 4735213

Traumatic choroidal rupture with late serous detachment of macula. Report of successful argon laser treatment.

B Fuller, K A Gitter.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4735213     DOI: 10.1001/archopht.1973.01000040356020

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  8 in total

Review 1.  The development of an experimental model of subretinal neovascularization in disciform macular degeneration.

Authors:  S J Ryan
Journal:  Trans Am Ophthalmol Soc       Date:  1979

2.  Idiopathic sub-retinal neovascular membranes in the macula (hemorrhagic macular choroidopathy of young adults). Clinical report and effectiveness of laser treatment.

Authors:  F G Bottoni; A F Deutman
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

3.  The disciform response: an historical perspective.

Authors:  S J Ryan; R N Mittl; A E Maumenee
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

4.  Indirect choroidal tears and late onset serosanguinous maculopathies.

Authors:  C D Hart; R Raistrick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

5.  Chorioretinal neovascular membranes complicating contusional eye injuries with indirect choroidal ruptures.

Authors:  C M Wood; J Richardson
Journal:  Br J Ophthalmol       Date:  1990-02       Impact factor: 4.638

6.  Birdshot retinochoroidopathy and subretinal new vessels.

Authors:  G Soubrane; G Coscas; M Binaghi; P Amalric; J A Bernard
Journal:  Br J Ophthalmol       Date:  1983-07       Impact factor: 4.638

7.  Indirect choroidal tears at the posterior pole: a fluorescein angiographic and perimetric study.

Authors:  J C Hart; V E Natsikos; E R Raistrick; R M Doran
Journal:  Br J Ophthalmol       Date:  1980-01       Impact factor: 4.638

8.  Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture.

Authors:  T Barth; F Zeman; H Helbig; M-A Gamulescu
Journal:  BMC Ophthalmol       Date:  2019-11-26       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.